(A) To establish gating parameters L1 worms were digested into a single cell suspension and stained with a live/dead stain. SSC (side scatter) and FSC (forward scatter) were used to select the …
(a) RNA-seq libraries generated from C. elegans neural cells were sequenced using an Illumina NextSeq500 from 3 independent biological replicates. The data was processed with our SAILOR software …
RNA was isolated (A–B) from wild-type (WT) and adr-2(-) neural cells (3 or 4 biological replicates) or (C) WT and adr-2(-) L1 whole worms (2 biological replicates). qRT-PCR was used to determine the …
(A) Lysates from adr-1(-) worms and worms expressing FLAG-ADR-1 were subjected to a FLAG immunoprecipitation (IP). qRT-PCR was performed on both RNA from the input lysates as well as the IP samples. …
RNA isolated from wild-type (WT) and adr-1(-) (A) neural cells or (B) whole L1 worms was subjected to reverse-transcription and PCR amplification followed by Sanger sequencing to assess editing …
RNA was isolated from neural cells from wild-type (WT) as well as WT +clec-41 and adr-2(-)+clec-41 transgenic worms expressing clec-41 using the pan-neural rab-3 promoter for (A) qRT-PCR analysis of …
The Chemotaxis Index of WT, adr-2(-) as well as (A) WT +gfp:clec-41 3' UTR and adr-2(-)+gfp:clec-41 3' UTR or (B) WT and adr-2(-) expressing clec-41 in pharyngeal muscle tissue (clec-41 transgene …
(A) Alignment of ADAR sequences from several species demonstrating conservation of the Glycine residue at position 184 in the C. elegans ADR-2 protein. This G is near the conserved HAE deamination …
Lysates from wild-type (WT), adr-1(-) and adr-2(-) worms were subjected to SDS-PAGE and immunoblotting with a custom ADR-2 antibody.
Sequence | ||
---|---|---|
qRT-PCR | ||
unc-64 | Forward | Gccattgatcacgacgagcaaggagccgga |
Reverse | Ccagcaatatcgagttgtctctgaattcgtc | |
myo-3 | Forward | ccagaagaatatcagacgctacttggac |
Reverse | taacaataagctcttcttgctcctgtttg | |
gpd-3 | Forward | ggaggagccaagaaggtc |
Reverse | aagtggagcaaggcagtt | |
ctl-2 | Forward | caagccaactcaaggagtgaagaatctcac |
Reverse | catcttccatactggaaagtctcccttctc | |
dod-19 | Forward | ccaggatatacgagcatcgattcgacaacc |
Reverse | gaagctccaggatatctagtatctctcttg | |
hsp12.6 | Forward | caatgtcctcgacgacgatgatcacttc |
Reverse | gaatccttctttacattgtgctccatatgg | |
sre-6 | Forward | gaaagatgctttgcgacatgtttcgctgg |
Reverse | cgggcatcatgatagaaatcaagagaag | |
clec-41 | Forward | actctggaagattctattccccaagc |
Reverse | cgactgtaaatggaaattgatgcctgac | |
Editing Assays | ||
daf-2 | RT primer | ctatttcgagcattgaggccgaattgaggc |
Forward #1 | cgagaatgaatgaatattgtcagatgtcggag | |
Reverse #1 | cgagcgctacgtcgaattccaataactc | |
Forward #2 | gaaaatttggaagaaggtgagctggggg | |
Reverse #2 | ggtgggttaccgaaatttgagactttgc | |
clec-41 | RT primer | acaccacgaaaaataattacagtgctggcc |
Forward #1 | ctcaacagattcatctggccaaggttcagg | |
Reverse #1 | acaccacgaaaaataattacagtgctggcc | |
Forward #2 | ggttcaggattcagtgcaaatttttgggcg | |
Reverse #2 | agctcgagattactctacacttctcttctt | |
npr-17 | RT primer | gctattgagttcattgagccatttacctggg |
Forward #1 | ccaacttcaacaaagatatcgatcaaatcg | |
Reverse #1 | cattgagccatttacctgggaaaatgtggc | |
Forward #2 | gacgacaacaacaacagcttcaacagc | |
Reverse #2 | gttccgtataagtgttttacccagaagcg | |
rbf-1 | RT primer | gtgtcaatgtgattgagccaaggctacctg |
Forward #1 | ggggttattcaagtagtttcgcaac | |
Reverse #1 | tgagccaaggctacctgaatattttg | |
Forward #2 | ggggttattcaagtagtttcgcaac | |
Reverse #2 | gtgagaagaagaggaagatggaatattgatg | |
crtc-1 | RT primer | ctctaatgccttcagattggcgccacctac |
Forward #1 | ccaccaaacacccaacaactcattccatg | |
Reverse #1 | ccttcagattggcgccacctacaacatgg | |
rgef-1 | RT primer | gaggaaagtgtgtggaagactggtg |
Forward #1 | ggaagtacaccagatgaagaaattggtcttg | |
Reverse #1 | gcgtagagatcaaacaagtgggatagg | |
F23A7.3 | RT primer | ctaactgccaacaaacgactatctcaaatg |
Forward #1 | cacaactctcttgctggataggtccgaacg | |
Reverse #1 | ctaactgccaacaaacgactatctcaaatg | |
Forward #2 | gctggataggtccgaacgtcgtctaatg | |
Reverse #2 | ctattctcatggagcatctgccattcc |
A-to-I editing sites identified in neural cells.
The high confidence editing sites identified by the bioinformatics pipeline are listed on the first sheet of the excel document (RNA-seq Identified Sites). The chromosome number (Column A) and coordinate in ce11 reference genome (Column B) are given for each predicted editing site. The approximate editing percentage (Column C) based on the frequency of reads with guanosine at that coordinate within unique reads as well as the number of unique reads covering that position (Column D) is listed. The predicted editing site was assigned (described in detail in the methods section) to a genic region (Column E) and a gene (Column F and G). A list of editing sites identified using Sanger sequencing editing assays from mRNAs identified by the bioinformatics pipeline are listed on the second sheet of the excel document (Sanger-seq Verification). Gene-specific reverse transcription followed by PCR amplification and Sanger sequencing was used to examine editing events in the indicated genes (Column A). The chromosome number (Column B) and coordinate in ce11 reference genome (Column C) are given for each adenosine to inosine detected as well as the percent editing as determined using the RNA-seq data (Column D). The methods used to detect the A-to-I change was listed (Column D and E) as well as confirmation (yes), decline (no), or inability to accurately determine (ND) the presence of A-to-I editing at a given adenosine. A list of all genes and the novel genes identified by the pipeline as edited are listed on the third sheet of the excel document (Edited Genes). All edited genes (Column A and B) were aligned with a document containing all identified editing sites in C. elegans from numerous published RNA-seq data sets (Supplementary file 3 [Goldstein et al., 2017]). Novel edited genes identified in this study are listed (Column C and D). Genes identified as edited by SAILOR were queried using Wormbase to identify genes that regulate chemotaxis and/or locomotion and these genes are listed on sheet four of the excel document (Locomotion and Chemotaxis Genes). The wormbase IDs and gene names (Column A and B) are listed for genes identified as regulators of this biological process. The genes were then aligned with an unpublished RNA-seq data set of RNAs bound by ADR-1 (Column C).
Differential gene expression identified from the transcriptome-wide RNA-seq.
Genes whose transcripts exhibited ≥2 fold change in expression between wild-type and adr-2(-) neural cells are listed. Upregulated (Sheet 1) and downregulated (Sheet 2) genes are listed by gene name (Column A) and Wormbase ID (Column B). The base Mean, or mean expression of each gene normalized to sequencing depth for all samples is listed (Column C), as well as the fold change in expression observed when comparing the wild-type to adr-2(-) (Column D) and the adjusted p-value from DESeq2 (Column E). Genes whose expression was examined by qRT-PCR are marked with yellow and listed as verified (Column F). The four edited genes are listed as Edited (Column G).